Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Biolog Device Co., Ltd. (208710:KRX), powered by AI.
Biolog Device Co., Ltd. is currently trading at ₩3,130. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Biolog Device Co., Ltd. on Alpha Lenz.
Biolog Device Co., Ltd.'s P/E ratio is -4.1.
“Biolog Device Co., Ltd. trades at a P/E of -4.1 (undervalued) with modest ROE of -17.0%. 3Y revenue CAGR of 17.4% highlights clear growth momentum.”
Ask for details →Biolog Device Co., Ltd. is a pivotal player in the medical technology sector, focusing on the design and manufacture of advanced diagnostic and therapeutic devices. The company is known for its innovative solutions in the field of biological testing and medical device manufacturing. Biolog Device Co., Ltd. specializes in producing equipment that supports critical healthcare diagnostics, impacting sectors such as hospitals, research laboratories, and clinical settings globally. The devices produced by the company enable healthcare professionals to perform accurate and efficient diagnostic evaluations, thus enhancing patient care and treatment outcomes. With a commitment to quality and precision, Biolog Device Co., Ltd. maintains a prominent role in the medical equipment market, addressing the growing demand for high-performance, reliable medical devices. The company collaborates with medical institutions and research bodies to continually improve and adapt its technology to meet the evolving needs of the healthcare industry.
“Biolog Device Co., Ltd. trades at a P/E of -4.1 (undervalued) with modest ROE of -17.0%. 3Y revenue CAGR of 17.4% highlights clear growth momentum.”
Ask for details →Biolog Device Co., Ltd. (ticker: 208710) is a company listed on KRX in the Technology sector (Electronic Components). It has approximately 35 employees. Market cap is $41.3B.
The current price is ₩3,130 with a P/E ratio of -4.1x and P/B of 0.74x.
ROE is -17.01% and operating margin is -2.54%. Annual revenue is $135.7B.